Additionally, there is mounting evidence that GDF-15 is involved in the pathophysiology of a number of metabolic disorders, including obesity-related insulin resistance and nonalcoholic fatty liver disease (NAFLD) [36, 41]. This evidence concerns the gene GDF15 and metabolic disease.